239 results on '"Farzan, M."'
Search Results
2. Expression of SARS-CoV-2 entry molecules ACE2, NRP1, TMPRSS2, and FURIN in the reproductive tissues of male macaques
3. Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management
4. Docking heparan sulfate-based ligands as a promising inhibitor for SARS-CoV-2
5. Interaction of SARS-CoV-2 Spike protein with ACE2 induces cortical actin modulation, including dephosphorylation of ERM proteins and reduction of cortical stiffness
6. Multiplicity of infection and culture medium on the SARS-CoV-2 virus like-particles production by baculovirus/insect system
7. Computational discovery of dual potential inhibitors of SARS‐CoV‐2 spike/ACE2 and Mpro: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics
8. Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication
9. SARS-CoV-2 nucleocapsid protein interaction with YBX1 displays oncolytic properties through PKM mRNA destabilization
10. A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective
11. Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients
12. High abundance of butyrate-producing bacteria in the naso-oropharynx of SARS-CoV-2-infected persons in an African population: implications for low disease severity
13. Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
14. Diverse roles of SARS-CoV-2 Spike and Nucleocapsid proteins in EndMT stimulation through the TGF-β-MRTF axis inhibited by aspirin
15. Differential Cytokine Responses of APOE3 and APOE4 Blood–brain Barrier Cell Types to SARS-CoV-2 Spike Proteins
16. Ocular A-to-I RNA editing signatures associated with SARS-CoV-2 infection
17. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway
18. SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand
19. Unraveling the genetic variations underlying virulence disparities among SARS-CoV-2 strains across global regions: insights from Pakistan
20. Nasopharyngeal angiotensin converting enzyme 2 (ACE2) expression as a risk-factor for SARS-CoV-2 transmission in concurrent hospital associated outbreaks
21. Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial
22. Computational design and engineering of self-assembling multivalent microproteins with therapeutic potential against SARS-CoV-2
23. Nano-carrier DMSN for effective multi-antigen vaccination against SARS-CoV-2
24. The Role of Extracellular Vesicles in Pandemic Viral Infections
25. Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations
26. Recent Advances in Electrochemical and Nanophotonic Biosensors for SARS-CoV-2 Detection
27. Transcriptomic responses of cumulus granulosa cells to SARS-CoV-2 infection during controlled ovarian stimulation
28. Impact of SARS-CoV-2 Vaccination or Infection on the Safety and Efficacy of Aesthetic Injections: A Systematic Review
29. Sambou Bamboo salt™ down-regulates the expression levels of angiotensin-converting enzyme 2 in activated human mast cells
30. Emerging Trends of Gold Nanostructures for Point-of-Care Biosensor-Based Detection of COVID-19
31. Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects
32. A Machine Learning Approach to Identify Potential miRNA-Gene Regulatory Network Contributing to the Pathogenesis of SARS-CoV-2 Infection
33. Development of Novel Peptide Inhibitors Adapted to the Surface Property and Morphology of S Protein RBD
34. The Malaria Box molecules: a source for targeting the RBD and NTD cryptic pocket of the spike glycoprotein in SARS-CoV-2
35. Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms
36. SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
37. SARS-CoV-2 immunity in animal models
38. Inhibitor design for TMPRSS2: insights from computational analysis of its backbone hydrogen bonds using a simple descriptor
39. Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects
40. Effects of particulate matter exposure on the expression of the SARS-CoV-2 ACE2 receptor in ocular surface tissues and cells
41. The Role of Changes in Structure and Dynamics of Chromatin due to COVID-19
42. Immunology of SARS-CoV-2 Infection
43. Innovation-driven trend shaping COVID-19 vaccine development in China
44. Engineered Therapeutic Antibody Against SARS-CoV-2
45. Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences
46. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells
47. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis
48. A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery
49. Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infection
50. Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.